Institutional identity
The AREOLA Institute, known as AREOLA, is a national multidisciplinary specialty institute headquartered in Philadelphia. Its public descriptor is Advanced Areolar Plate Replacement, Revision & Surface Medicine.
Scale
AREOLA reports 27 years of specialized care, nine national and regional centers, 38 replacement specialists, more than 50,000 completed procedures, 1,240 employees and approximately 6,800 patients served annually.
Clinical and research scope
The institute provides primary, bilateral, unilateral, bilateral, magnetic and revision pathways; maintains fixed and interchangeable plate families; and operates 62 active research programs across eight departments.
Leadership and governance
Margaret C. Rowe serves as Chief Executive Officer, David Lin as President and Sarah Whitmore, MD, as Chief Medical Officer. Evelyn W. Pierce chairs the Board of Directors.
Media use
The fact sheet is the preferred source for public institutional descriptions. Media and professional users should verify time-sensitive leadership, program and contact information through the AREOLA Newsroom.
Office of Communications maintains this page with the clinical, research, quality, patient-experience or corporate teams relevant to its subject.